Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Liminatus Pharma Inc. (LIMN) had Earnings per Share (EPS) (Basic) of $-2.55 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.00M |
|
-- |
|
-- |
|
$-0.00M |
|
$0.00M |
|
-- |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
0.00M |
|
0.00M |
|
|
Earnings per Share (EPS) (Basic) |
$-2.55 |
$-2.55 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$-0.00M |
|
$-0.00M |
|
$-0.00M |
|
0.00M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|